2000 Goody's Body Pain 500

Congressional Recognition for Historic Fibromyalgia Social Good Effort for Veterans and the Chronically Ill

Retrieved on: 
Saturday, July 1, 2023

Kristal Kent shared with our team language from the proclamation request and outreach goals to get more supporters in various roles in our communities.

Key Points: 
  • Kristal Kent shared with our team language from the proclamation request and outreach goals to get more supporters in various roles in our communities.
  • "WHEREAS Fibromyalgia is a chronic-pain disorder that causes widespread body pain; affecting 3-5% of the population in the United States (Source: "Fibromyalgia - A Clinical Review" by Dr. Daniel J. Claw, April 16, 2014).
  • She added, "Congresswoman Nanette Diaz Barragan's recognition of the work we are doing to help others who suffer with Fibromyalgia means so much to our team.
  • I am so grateful for this opportunity and the support of my government representative."

Benzodiazepine Use Associated with Brain Injury, Job Loss, and Suicide

Retrieved on: 
Friday, June 30, 2023

Previous studies had described this injury with various terminologies, perhaps the most well-known being protracted withdrawal.

Key Points: 
  • Previous studies had described this injury with various terminologies, perhaps the most well-known being protracted withdrawal.
  • The survey of 1207 benzodiazepine users from benzodiazepine support groups and health/wellness sites is the largest of its kind.
  • BIND is thought to be a result of brain changes resulting from benzodiazepine exposure.
  • The survey was a collaborative effort between CU Anschutz, Vanderbilt University Medical Center, and several patient-led advocacy organizations that educate on benzodiazepine harms.

The first Post-COVID Syndrome Phase II clinical trial has begun recruiting patients.

Retrieved on: 
Thursday, May 25, 2023

BALDWIN PARK, Calif., May 25, 2023 /PRNewswire/ -- StemCyte announced it has officially begun recruiting patients under a US Food and Drug Administration (FDA) approved Phase IIa human clinical trial in the United States.

Key Points: 
  • BALDWIN PARK, Calif., May 25, 2023 /PRNewswire/ -- StemCyte announced it has officially begun recruiting patients under a US Food and Drug Administration (FDA) approved Phase IIa human clinical trial in the United States.
  • This is the world's first Phase II trial using umbilical cord blood cells to treat Post-COVID syndrome.
  • Cord Blood is a cell therapy biological drug that StemCyte is investigating to repair symptoms of Post-COVID Syndrome.
  • Currently, Pfizer's Paxlovid Phase III clinical trial and StemCyte's HPC, Cord Blood complement each other in treating Post-COVID Syndrome.

MLILY: Focusing on Innovation and R&D of Zero Pressure Sleep Technology

Retrieved on: 
Friday, March 10, 2023

MLILY takes the concern for reality, concern for body and mind, and care for sleep as starting point, focusing on innovation and R&D of zero pressure sleep technology, dedicated to creating a restful, rejuvenating sleep environment for people's body and mind, and bringing quality deep sleep to customers worldwide.

Key Points: 
  • MLILY takes the concern for reality, concern for body and mind, and care for sleep as starting point, focusing on innovation and R&D of zero pressure sleep technology, dedicated to creating a restful, rejuvenating sleep environment for people's body and mind, and bringing quality deep sleep to customers worldwide.
  • MLILY integrates the manufacture of mattresses and other sleep products with the goal of helping people get better deep sleep, and has been focusing on the research and improvement of mattress materials.
  • Deep sleep requires a good mattress.
  • Mental stress is relieved through 8 hours of sleep, and physical stress is released through zero pressure sleep technology.

Mucinex® Fast-Max Cold & Flu All In One Teams Up with Two-Time Olympic Gold Medalist, Chloe Kim to Launch "Small But Mighty" Campaign

Retrieved on: 
Wednesday, February 22, 2023

PARSIPPANY, N.J., Feb. 22, 2023 /PRNewswire/ -- As we all continue to navigate another hard-hitting cold and flu season, Mucinex – a Reckitt brand and America's #1 doctor trusted cough & cold brand – is on a mission to help communities everywhere feel better, stay well and comeback from their cold and flu symptoms. Mirroring the powerful multi-symptom relief that Mucinex Fast-Max offers with one small dose, the brand is launching its Small But Mighty Campaign to show consumers that they can treat their cold & flu with less liquid per dose. *

Key Points: 
  • "The Small But Mighty Campaign illustrates how powerful relief can start with one small dose, and that consumers can take control over their cold & flu symptoms with Mucinex Fast-Max All In One."
  • Teaming up with Mucinex is one of the most celebrated winter athletes in recent years, two-time Olympic gold medalist, Chloe Kim, the first female in history to win back-to-back Olympic gold medals in halfpipe snowboarding.
  • "I am thrilled to partner with Mucinex to help bring awareness of the impact something 'small but mighty' can have during this cold & flu season," said Chloe Kim.
  • "50% more concentrated per ml vs the leading daytime severe cold & flu remedy* (Source: Nielsen latest 52 weeks ending 10/2022)."

How Stirling CBD is Helping an Elite Crossfit Athlete Excel in Her Craft

Retrieved on: 
Monday, December 19, 2022

This plight of sore muscles and body aches led one CrossFit athlete, Jennifer Armour, to search for alternative solutions to managing pain.

Key Points: 
  • This plight of sore muscles and body aches led one CrossFit athlete, Jennifer Armour, to search for alternative solutions to managing pain.
  • Jennifer's love for Crossfit is what led her to discover CBD products.
  • As an athlete, she often experiences sore muscles due to the high-intensity workouts involved in CrossFit.
  • A close friend, who was also using CBD, introduced her to Stirling CBD.

Surgical Navigation Systems Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Tuesday, January 3, 2023

The surgical navigation systems market is expected to grow to $10.73 billion in 2026 at a CAGR of 12.3%.

Key Points: 
  • The surgical navigation systems market is expected to grow to $10.73 billion in 2026 at a CAGR of 12.3%.
  • The main types of technologies in surgical navigation systems are electromagnetic navigation systems, optical navigation systems, hybrid navigation systems, fluoroscopy-based navigation systems, CT-based navigation systems, and others.Electromagnetic navigation system refers to the use of electromagnetic wave-assisted software to gather an image of soft tissue or cavity of the body to perform surgery.
  • The various applications include neurosurgery navigation systems, orthopedic navigation systems, ENT navigation systems, dental navigation systems, and others that are used by hospitals, physician practices, and ambulatory settings end users.
  • The surgical navigation systems market research report is one of a series of new reports that provides Surgical navigation systems market statistics, including surgical navigation systems industry global market size, regional shares, competitors with surgical navigation systems market share, detailed Surgical navigation systems market segments, market trends, and opportunities, and any further data you may need to thrive in the surgical navigation systems industry.

Fuheng Herbs Announces New Business Location and New Chinese Herbal Medicine Store to Better Meet the Needs of Patients in the Silicon Valley Community

Retrieved on: 
Friday, November 11, 2022

"The new location marks an important step to better provide services and treatments to patients," said Dr. Dalong Zhang, founder of Fuheng Herbs.

Key Points: 
  • "The new location marks an important step to better provide services and treatments to patients," said Dr. Dalong Zhang, founder of Fuheng Herbs.
  • Dr. Zhang used Chinese medicine diagnosis techniques and designed a treatment plan which included energy therapy, acupuncture, and Chinese herbs.
  • Fuheng Herbs develops and manufactures Chinese herbal supplements and herbal teas and distributes Chinese herbs.
  • He recently launched his flagship Chinese herbal medicine store, providing patients in the Silicon Valley community the convenience of getting their herbal teas, supplements, and herbs 24x7.

Global Aspirin Market Report 2022: Growing Demand for Branded Generics to Boost Sector - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 4, 2022

The "Global Aspirin Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Aspirin Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global aspirin market size is estimated to augment at a CAGR of 2.40%, increasing from US$2.167 billion in 2020 to reach US$2.558 billion by 2027.
  • The growing demand for branded generics will continue to propagate market growth during the forecast period.
  • The prevalence of headaches worldwide will fuel the market demand for analgesics, further augmenting the market growth during the forecast period.

Kailo Pain Patch: All Natural Patch Changes Everything

Retrieved on: 
Thursday, July 7, 2022

Pain Relief Technologies LLC introduced an all-natural pain relief patch that has quickly risen to the top of the market.

Key Points: 
  • Pain Relief Technologies LLC introduced an all-natural pain relief patch that has quickly risen to the top of the market.
  • Kailo Pain Relief Patch is a non-transdermal, re-usable, and innovative technological patch that is designed to naturally relieve pain in just a few seconds.
  • According to The Journal of Anesthesia and Pain Research , the effectiveness of the Kailo Pain Patch was tested in a clinical trial.
  • The Kailo Pain Relief Patch is designed to interact with your body's natural electrical system to reduce pain signals and help you feel better.